(S1 (S (S (NP (NP (JJ Neoplastic) (NN progression)) (PP (IN of) (NP (JJ human) (JJ colorectal) (NN cancer)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN overexpression)) (PP (IN of) (NP (DT the) (NP (NP (NN stromelysin-3)) (CC and) (NP (NN BM-40/SPARC))) (NNS genes)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN of) (NP (JJ neoplastic) (NNS cells))) (PP (IN with) (NP (DT the) (JJ extracellular) (NN matrix)))) (VP (VBZ is) (NP (NP (DT a) (JJ critical) (NN event)) (PP (IN for) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN cancer) (NP (NN invasion)) (CC and) (NP (NN metastasis))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ potential) (NN implication)) (PP (PP (IN of) (NP (NP (NP (NN stromelysin-3)) (PRN (-LRB- -LRB-) (NP (NN ST3)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (ADJP (RB newly) (VBN identified)) (NN member)) (PP (IN of) (NP (DT the) (JJ matrix-degrading) (NN metalloproteinase) (NN family)))))) (, ,) (CC and) (PP (IN of) (NP (NP (NN BM-40/SPARC)) (, ,) (NP (NP (DT a) (NN glycoprotein)) (VP (VBN associated) (PP (IN with) (NP (DT the) (JJ extracellular) (NN matrix))))))))) (, ,) (PP (IN during) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (JJ human) (JJ colorectal) (NNS cancers))))))))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBD analyzed) (NP (NP (DT the) (JJ relative) (NN abundance)) (PP (IN of) (NP (NP (NP (NN ST3)) (CC and) (NP (NN BM-40/SPARC))) (NNS transcripts)))) (PP (IN by) (NP (NP (NN Northern) (NN blot)) (, ,) (CC and) (NP (PRP$ their) (NN distribution)))) (PP (IN by) (NP (ADJP (FW in) (FW situ)) (NN hybridization))) (, ,) (PP (IN in) (NP (NP (JJ normal) (NN mucosa)) (, ,) (NP (JJ benign) (NNS adenomas)) (, ,) (CC and) (NP (JJ primary) (JJ colorectal) (NNS adenocarcinomas)) (CC and) (NP (PRP$ their) (NN liver) (NNS metastases))))) (. .)))
(S1 (S (S (NP (DT The) (NP (NP (NN ST3)) (CC and) (NP (NN BM-40/SPARC))) (NNS transcripts)) (VP (VBD were) (VP (VBN overexpressed) (PP (IN in) (NP (NP (JJ primary) (JJ colorectal) (NNS cancers)) (CC and) (NP (PRP$ their) (NN liver) (NNS metastases)))) (PP (VBN compared) (PP (TO to) (NP (JJ non-neoplastic) (NN mucosa))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS transcripts)) (VP (VBD were) (VP (VBN localized) (PP (IN in) (NP (NP (JJ stromal) (NNS fibroblasts)) (ADJP (JJ adjacent) (PP (TO to) (NP (DT the) (JJ neoplastic) (NNS foci))))))))) (. .)))
(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN ST3)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (JJ human) (JJ colorectal) (NNS tumors))) (PP (IN toward) (NP (NP (JJ local) (NN invasion)) (CC and) (NP (NN liver) (NN metastasis)))))))) (. .)))
(S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (DT these) (NNS genes)))) (ADVP (RB also)) (VP (VBD occurred) (PP (IN in) (NP (NP (NN diverticulitis)) (CC and) (NP (NP (JJ digestive) (NNS neoplasms)) (PP (JJ such) (IN as) (NP (NP (ADJP (JJ gastric))) (CC and) (NP (ADJP (JJ esophageal))) (NP (NNS carcinomas))))))))) (. .)))
